series	seriesDescription	geoAreaCode	geoAreaName	timePeriodStart	value	valueType	time_detail	upperBound	lowerBound	basePeriod	source	footnotes	Nature	Units	Reporting Type
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	24	Angola	2013.0	9	Float					WHO/UNICEF coverage estimates 2018 revision, July 2019	['']	E	PERCENT	G
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	24	Angola	2014.0	45	Float					WHO/UNICEF coverage estimates 2018 revision, July 2019	['']	E	PERCENT	G
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	24	Angola	2015.0	58	Float					WHO/UNICEF coverage estimates 2018 revision, July 2019	['']	E	PERCENT	G
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	24	Angola	2016.0	59	Float					WHO/UNICEF coverage estimates 2018 revision, July 2019	['']	E	PERCENT	G
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	24	Angola	2017.0	59	Float					WHO/UNICEF coverage estimates 2018 revision, July 2019	['']	E	PERCENT	G
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	24	Angola	2018.0	67	Float					WHO/UNICEF coverage estimates 2018 revision, July 2019	['']	E	PERCENT	G
